A recent preprint from the University of Pennsylvania (Penn) showed that lipid nanoparticles, which transport COVID-19 mRNA in COVID-19 vaccines, cause inflammation within cells. However, this inflammation can be reduced if the proper lipid nanoparticle is used.
The researchers tested several different lipid nanoparticle formulations in animals, including ALC-0315 and SM-102, used in Pfizer’s and Moderna’s COVID-19 vaccines, respectively.





